Dr. Danyi Zhang, is the founder of VitalStrategic Research Institute, she also serves as the President & Chief Medical Officer. She received her medical education from China and post-graduate education from the US. She completed her academic training at Massachusetts Institute of Technology (Cambridge, MA) and Harvard Medical School (Cambridge, MA). Her research interests included laser medicine, percutaneous transluminal coronary angioplasty, thrombotic conditions, anti-thrombotic and anti-platelet therapies.
Prior to founding VitalStrategic Research Institute, Dr. Zhang has had a successful career in pharmaceutical industry and held increasing global leadership positions in clinical research and development, strategic planning and medical affairs. 

VitalStrategic Research Institute is the first independent research firm that focuses on outcomes research and late phase clinical trials in China. Collaborating with Chinese Medical Doctor Association, we have made significant contribution to the establishment of national disease registries, including China Cardiometabolic Resgiestries (CCMR), China Chronic Disease Registries (CCDR). Dr. Zhang is also the founder and the Chairman of the Advisory Council of the annual international conference, China Outcomes Research and Evidence Based Medicine (CORE) Summit, one of the largest conferences in Asia that focuses on real world evidence, comparative effectiveness research, cost effectiveness, health technology assessment, valued health, personalized medicine, electronic health, and big data. 

The leadership team in VitalStrategic is composed of individuals who have had successful track records of research in both industry and academics and who represent field expertise in medical, bio-statistics, data management, clinical operation, information technology, and health economics.